$DSS PR soon with Impact Biomedical IPO details (ie IPO price, timeline, next dividend report date etc.) + A&E bottom forming on the daily = $$$ + Addtl info (from my previous post): $DSS owns ~65,000,000 shares of $SHRG $DSS purchased these shares of SHRG in Q2 2020 (when SHRG was trading at ~ $.08). Legal proceedings against SHRG have since been settled causing its SP to reach $.73, and now seems to be trading comfortably at $.25. You'll note in the screenshot that this increase just so happened to begin a few days after July 1 (start of Q3) at $.09. SHRG later closed the quarter at $.25. As a result, $DSS will report an unrealized gain of ~$10.5M on its Q3 balance sheet. I do believe this was planned as it will attract more investors with its sudden enhanced stockholders equity, rather than having it bleed into multiple quarters. Also, $SHRG reported last week that their new product sold out within an hour. Have a read: finance.yahoo.com/news/shar...
  • 6
6 Likes